Company

Sophiris Bio, Corp.

Sophiris Bio develops a treatment for urological diseases.

About

Sophiris Bio is a biopharmaceutical company developing topsalysin (PRX302) for urological diseases. Founded in 2002, it is based in California, US, and is public.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in